Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nor Azman N. I. Iwana"'
Autor:
Hatem A. Abuelizz, Nor Azman N. I. Iwana, Rohaya Ahmad, El-Hassane Anouar, Mohamed Marzouk, Rashad Al-Salahi
Publikováno v:
BMC Chemistry, Vol 13, Iss 1, Pp 1-14 (2019)
Abstract Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial gluco
Externí odkaz:
https://doaj.org/article/637eca829d9b45768e8a6d4a7065afc0
Autor:
Nor Azman N. I. Iwana, Rashad Al-Salahi, Mohamed Marzouk, El Hassane Anouar, Hatem A. Abuelizz, Rohaya Ahmad
Publikováno v:
BMC Chemistry, Vol 13, Iss 1, Pp 1-14 (2019)
BMC Chemistry
BMC Chemistry
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level.
Autor:
Rashad Al-Salahi, Mohamed Marzouk, El Hassane Anouar, Nor Azman N. I. Iwana, Rohaya Ahmad, Hatem A. Abuelizz
Diabetes is an emerging metabolic disorder. α-Glucosidase inhibitors, such as acarbose, delay the hydrolysis of carbohydrates by interfering with the digestive enzymes. This action decreases the glucose absorption and the postprandial glucose level.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4f136cf48b2909e9e5aa4246f045ae